FDA Investigator Heriberto Negron Rivera

Heriberto Negron Rivera has conducted inspections on 36 sites in 10 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
36
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100003559
Countries of Inspections:
India, China, Argentina, Mexico, Italy, Taiwan, Israel, Spain, United States of America, Dominican Republic
FDA Investigators that have inspected at least one site in common with Heriberto Negron Rivera:
Alan L Truong, Alan M Barker, Alicia M Mozzachio, Amir Alavi, Ana P Pineda Zavaleta, Anastasia M Shields, Anissa M Vargas, Anita R Michael, Anthony A Charity, Ariel Cruz Figueroa, Azza Talaat, Barbara I Rogolsky, Barbara J Rincon, CDR Rochelle B Young, RPh, MSA, Christopher M Jenner, Christopher R Czajka, Claudia Mperez Kasmarski, Concepcion Cruz, Jr, Craig D Zagata, Delaram Moshkelani, Dennis Cantellops Paite, Doan T Nguyen, PharmD, Dongping Dai, PhD, Douglas C Kovacs, Dr. Carmelo Rosa, Edwin Melendez, Emest F Bizjak, Eric M Mueller, PharmD, Erika V Butler, Felix Maldonado, Gam S Zamil, Gerardo Z Vazquez, German Rivera, Gwyn G Dickinson, H Ljamilla Selby, Hala L Selby, Helen B Ricalde, James C Maclaughlin, Javier E Santos, Jawaid Hamid, Jeffrey A Sommers, Jessica L Pressley, Jill J Tillman, Joan M Cantellops Figueroa, Joel D Hustedt, Jose A Lopez, Jose M Cayuela, Jose R Hernandez, Joseph L Despins, PhD, Joshua P Wireman, Julianne C Mccullough, Karthik B Iyer, Karyn M Campbell, Katherine Szestypalow, Kelly I Anderson, Kendra L Brooks, Kent C Faul, Kham Phommachanh, Kim Lthomas Cruse, Kristina J Donohue, Kristina Mjoyce Pittman, LCDR Susan E Polifko, Leonard H Lavi, Liatte Kreuger, PharmD, Libia M Lugo, Lisa Shin, Lloyd D Payne, Lourdes Valentin Aponte, Lucas B Leake, Luis A Carrion, Luis A Dasta, Margaret A Smithers, Margaret M Annes, Maria Pkelly Doggett, MBA, Marianela Aponte Cruz, Marvin D Jones, Mary Davis Lopez, Matthew B Casale, Matthew R Noonan, Michael A Taylor, Michael C Rogers, Michael J Kuchta, Michael L Casner, Michele L Obert, Miguel A Martinez Perez, Monika Borkowska, Mra Davism, Mra Mcculloughj, Muna Algharibeh, Nicholas L Hunt, Nicole E Knowlton, Niketa Patel, Nikhil Thakur, Patricia H Dlugosz, Patrick L Wisor, Peter C Chow, Rafael E Arroyo, Rafael Nevarez Nieves, Raphael E Brykman, Raquel Gonzalez Rivera, Reba A Gates, Robert C Coleman, Robert R Wilson, Robin P Mathew, Rochelle K Kimmel, Rosa J Motta, Rose Ljean Mary, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Sandra A Hughes, Sangeeta M Khurana, PhD, Satheesh Thomas, Sharon K Thoma, PharmD, Simone E Pitts, Stefanie L Heckman, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven D Kehoe, Steven P Donald, Susan F Laska, MS, Susan W Ting, Syeda N Mahazabin, Tamil Arasu, PhD, Tara R Gooen, Temar Q Williams, Tenzin Jangchup, Thomas E Friel, Thomas J Arista, Tiara Nbrown Crosen, Tiffani D Wilson, Tracey L Harris, Truong Xuan Nguyen (Andy), Unnee Ranjan, Vlada Matusovsky, Walden H Lee, Yvonne C Mcknight, Yvonne C Wood, Zhongren Wu, Zi Qiang Gu

Heriberto Negron Rivera's Documents

Publish Date Document Type Title
May, 2015 FDA 483 Austin Biotechnology Inc. - Form 483, 2015-05-29
June, 2015 FDA 483 Lotus Pharmaceutical Co., Ltd. Nantou Plant - Form 483, 2015-06-04
February, 2010 FDA 483 Lannett Company, Inc. - Form 483, 2010-02-09
October, 2012 EIR Laboratorios Liomont, S.A. de C.V. - EIR, 2012-10-19
October, 2012 FDA 483 Organo Sintesis, S.A. de C.V. - Form 483, 2012-10-25
August, 2016 FDA 483 Laboratorios Roldan S.A. - Form 483, 2016-08-19
March, 2012 EIR Industrias Químicas Falcón de México, S.A. de C.V. - EIR, 2012-03-30
May, 2015 FDA 483 Ko Da Pharmaceutical Co Ltd - Form 483, 2015-05-27
November, 2012 EIR Instituto Massone S.A. - EIR, 2012-11-01
July, 2013 FDA 483 Sicor de Mexico S.A. de C.V. - Form 483, 2013-07-26
February, 2010 FDA 483 Lannett Company, Inc. - Form 483, 2010-02-09
March, 2012 FDA 483 Industrias Químicas Falcón de México, S.A. de C.V. - Form 483, 2012-03-30
September, 2011 FDA 483 SIPRA LABS LIMITED - Form 483, 2011-09-28
September, 2015 FDA 483 Huzhou Aupower Sanitary Commodity - Form 483, 2015-09-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more